Previous 10 | Next 10 |
• P roceeds to support continued development and commercialization of Endocrine Rare Disease products and general corporate purposes NEW YORK and COPENHAGEN, Denmark, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Ascendis Pharma A/S (Nasdaq: ASND) today...
Expect to resubmit NDA to FDA for TransCon™ PTH in October 2023; EC decision on MAA for TransCon PTH expected during the fourth quarter of 2023 U.S. and EU regulatory authorities endorsed ApproaCH as a pivotal Phase 3 trial of TransCon CNP in children with achondroplasia; e...
- Approximately 50% of Phase 3 PaTHway Trial patients with eGFR < 60 mL/min/1.73m 2 , the threshold for kidney dysfunction, receiving TransCon PTH experienced eGFR improvement to above 60 mL/min/1.73m 2 . COPENHAGEN, Denmark, Sept. 05, 2023 (GLOBE NEWSWIRE...
- Proceeds to support continued development and commercialization of Endocrine Rare Disease products, and general corporate purposes COPENHAGEN, Denmark and NEW YORK, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) and Royalty Pharma plc (Nasdaq: RPRX) today announce...
AeroVironment Inc. (AVAV) is expected to report $0.4 for Q1 2024 Jeronimo Martins - S.G.P.S., S.A. ADR (JRONY) is expected to report $0.74 for Q2 2023 TuSimple Holdings Inc. (TSP) is expected to report $-0.63 for Q2 2023 CVR Medical Corp (CRRVF) is expected to report for quarter end 2...
Ascendis Pharma A/S (ASND) is expected to report $-2.68 for Q2 2023
2023-09-04 17:35:00 ET Major earnings expected after the bell on Tuesday include: Zscaler ( ZS ) Asana ( ASAN ) AeroVironment ( AVAV ) Grindrod Shipping Holdings Ltd. ( GRIN ) For further details see: Notable earnings after Tuesday's close
2023-09-01 14:21:59 ET Wedbush has added Geron ( NASDAQ: GERN ) to its Best Ideas List, a recent sell-off in shares and its “high acquisition potential.” The investment bank said it believes Geron shares have been “unfairly sold off” in the wake of an...
COPENHAGEN, Denmark, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that Jan Mikkelsen, President & Chief Executive Officer, and Scott Smith, Executive Vice President & Chief Financial Officer, will participate in three upcoming investor conferences. ...
Ascendant Resources Announces Results of Annual and Special Meeting of Shareholders Canada NewsWire TSX: ASND www.ascendantresources.com All matters overwhelmingly approved by shareholders TORONTO , Aug. 23, 2023 /CNW/ - Ascendant Resource...
News, Short Squeeze, Breakout and More Instantly...
Pendopharm signs exclusive distribution agreement with Ascendis Pharma A/S for TransCon™ PTH in Canada Canada NewsWire MONTREAL , July 4, 2024 /CNW/ - Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distributio...
• Data demonstrate significant improvements in well-being and physical functioning compared to placebo in patients treated for 1 year with TransCon CNP at the pivotal 100μg/kg/week dose • Improvements could not be explained by changes in linear growth only, supporti...
2024-06-19 21:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...